15-hydroxyeicosatrienoic acid

the 15-lipoxygenase product of dihomogammalinolenic acid; inhibits the biosynthesis of the proinflammatory eicosanoids leukotriene B4 (LTB4) and 12-hydroxyeicosatetraenoic acid

Also Known As:

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Arai, Yoshino Taira: 1 article (01/2024)
2.	Hirayama, Kazuhiro: 1 article (01/2024)
3.	Horikami, Daiki: 1 article (01/2024)
4.	Kobayashi, Koji: 1 article (01/2024)
5.	Murata, Takahisa: 1 article (01/2024)
6.	Nagata, Nanae: 1 article (01/2024)
7.	Ozaki, Noriko: 1 article (01/2024)
8.	Sakamoto, Naoaki: 1 article (01/2024)
9.	Sone, Masayoshi: 1 article (01/2024)
10.	Tachibana, Yuri: 1 article (01/2024)

Related Diseases

1.	Pneumonia (Pneumonitis) 07/01/1997 - "Taken together, data from these studies suggest that dietary GLA-containing oil contributes to tissue elevation of PGE1 and 15-HETrE, which in vivo may attenuate lung inflammation and fibrosis."
2.	Fibrosis (Cirrhosis) 07/01/1997 - "Taken together, data from these studies suggest that dietary GLA-containing oil contributes to tissue elevation of PGE1 and 15-HETrE, which in vivo may attenuate lung inflammation and fibrosis."
3.	Hyperplasia 08/01/2000 - "15-HETrE, on the other hand, reversed the DHA-induced epidermal hyperplasia, and upregulated epidermal AP-1 expression. "
4.	Dyspnea (Shortness of Breath) 01/28/2024 - "Intranasal administration of 15-HETrE elicited dyspnea-related behavior and decreased the nasal cavity volume in mice. "
5.	Ischemic Stroke 10/04/2023 - "Administration of 15-HETrE enhanced functional recovery after ischemic stroke. "

Related Drugs and Biologics

1.	Alprostadil (Muse)
2.	Transcription Factor AP-1 (Transcription Factor AP 1)

Related Therapies and Procedures

1.	Intranasal Administration